Cecilia Jones, MBA

Cecilia Jones is the Chief Financial Officer of Agios Pharmaceuticals, Inc. (Agios) and a member of the company’s Leadership Team. She joined Agios in September 2022 and leads all aspects of the company’s financial strategy and operations, including corporate finance, accounting, investor relations, and corporate communications. Ms. Jones plays a key role in shaping Agios’ overall business direction and long-term growth plans in support of its vision to redefine the future of rare disease treatment.

Before joining Agios, Ms. Jones served as Chief Financial Officer at LogicBio, where she again led the company’s financial strategy and execution, guiding financing initiatives and evaluating opportunities to support growth and innovation.

Earlier in her career, Ms. Jones spent more than a decade at Biogen in senior finance leadership roles, most recently as Vice President of Research and Development, Worldwide Medical, and Business Development Finance. She also held finance positions of increasing responsibility at Genzyme, where she gained extensive international experience.

Ms. Jones is on the Board of Latinos in Bio, a position she has held since the group’s inception. The organization is dedicated to advancing the representation and success of Latino professionals across the life sciences industry, fostering community, visibility, and opportunity. She is also the co-Leadership Team sponsor of Agios’ Diversity Council, which advocates for an inclusive workplace and ensures accountability for initiatives that promote an environment where all employees can thrive.

She earned a Bachelor’s degree in Economics (Licenciatura en Economía) from Universidad de San Andrés in Buenos Aires, Argentina, and a Master of Business Administration (MBA) from Harvard Business School.